Tic Disorders Clinical Trials

83 recruitingLast updated: June 18, 2026

There are 83 actively recruiting tic disorders clinical trials across 26 countries. Studies span Not Applicable, Phase 2, Phase 1. Top locations include Boston, Massachusetts, United States, Paris, France, New York, New York, United States. Updated daily from ClinicalTrials.gov.


Tic Disorders Trials at a Glance

83 actively recruiting trials for tic disorders are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 52 trials, with the heaviest enrollment activity in Boston, Paris, and New York. Lead sponsors running tic disorders studies include Charite University, Berlin, Germany, Azienda Ospedaliero-Universitaria di Parma, and Assistance Publique - Hôpitaux de Paris.

Browse tic disorders trials by phase

Treatments under study

About Tic Disorders Clinical Trials

Looking for clinical trials for Tic Disorders? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tic Disorders trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tic Disorders clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 83 trials

Recruiting
Not Applicable

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

Depressive DisorderPsychotic DisordersAnxiety Disorders+1 more
Massachusetts General Hospital70 enrolled1 locationNCT05962879
Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hodgkin LymphomaNon-Hodgkin LymphomaHematologic Malignancies+14 more
Center for International Blood and Marrow Transplant Research99,999 enrolled142 locationsNCT01351545
Recruiting
Not Applicable

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

Psychotic DisordersAnxiety DisordersMood Disorders
Parnassia Groep2,500 enrolled9 locationsNCT05656469
Recruiting

Semantic and Syntactic Computerized Analysis of Free Speech

Psychotic DisordersPsychosisSchizophrenia and Related Disorders+2 more
University Hospital, Brest215 enrolled3 locationsNCT03525054
Recruiting
Not Applicable

Using a Speech-Generating Device to Support Communication in Rare Genetic Conditions

Genetic DiseaseRare Genetic DisordersNonverbal Communication+2 more
Murdoch Childrens Research Institute38 enrolled1 locationNCT07039084
Recruiting
Not Applicable

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

Cognitive DysfunctionPsychotic DisordersCannabis Use+5 more
Douglas Mental Health University Institute134 enrolled1 locationNCT05445180
Recruiting
Not Applicable

A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

Psychotic DisordersAnxiety DisordersMood Disorders
Massachusetts General Hospital192 enrolled1 locationNCT06929442
Recruiting
Not Applicable

Remote Delivery of a Mindfulness-based Intervention for Tics

Tic DisordersTourette SyndromeTourette's Disorder+5 more
Johns Hopkins University150 enrolled1 locationNCT06408662
Recruiting
Not Applicable

Racial Disparities in the Expression of Paranoia

Psychotic DisordersParanoia
Indiana University480 enrolled1 locationNCT07460453
Recruiting

Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

Bipolar Affective DisorderSevere Mental IllnessSchizophrenia Spectrum & Other Psychotic Disorders
Bjorn H. Ebdrup75 enrolled1 locationNCT06743711
Recruiting
Not Applicable

Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Acting Injectable Antipsychotics

Psychotic DisordersSevere Mental IllnessSchizophrenia Spectrum Disorders (SSD)
University of Trás-os-Montes and Alto Douro44 enrolled1 locationNCT07360665
Recruiting
Not Applicable

REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in Psychosis

Schizophrenia Spectrum & Other Psychotic Disorders
University of Toronto38 enrolled1 locationNCT07569471
Recruiting
Phase 1

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NeoplasmLymphoproliferative DisordersNeoplasms by Histologic Type+11 more
Kelonia Therapeutics, Inc.70 enrolled7 locationsNCT07075185
Recruiting
Not Applicable

Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis

SchizophreniaPsychotic DisordersSchizo Affective Disorder
The Royal Ottawa Mental Health Centre52 enrolled1 locationNCT05973110
Recruiting

Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders

Traumatic Brain Injury (TBI)Hypoxic-ischemic encephalopathy (HIE)Williams Syndrome+20 more
Healing Hope International100 enrolled1 locationNCT07493096
Recruiting
Not Applicable

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

Schizophrenia Spectrum DisordersPsychotic Disorders
Charite University, Berlin, Germany60 enrolled1 locationNCT07455929
Recruiting

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

SchizophreniaSchizoaffective DisorderDelusional Disorder+4 more
Beth Israel Deaconess Medical Center320 enrolled6 locationsNCT06740383
Recruiting

Neurogenetics Patient Registry

Neurogenetic Disorders
University of Pittsburgh1,000 enrolled1 locationNCT02995538
Recruiting

Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders

Acute Pancreatitis (AP)Thrombotic Disorders
RenJi Hospital10 enrolled1 locationNCT07450898
Recruiting
Not Applicable

Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

SchizophreniaSchizophrenia Spectrum DisordersPsychotic Disorders+3 more
Charite University, Berlin, Germany60 enrolled1 locationNCT07395206